1Carey MC,Kwon RS,Maurer KJ,et al.State of the artgallstone research in the post-genomic era[M]// Adler G,Blum HE,Fuchs M,et al,eds.Gallstones:pathogenesis and treatment.Dordrecht:Kluser Academic Publishers.2004:207-224.
2Katsika D,Grjibovski A,Einarsson C,et al.Genetic and environmental influences on symptomatic gallstone disease:a Swedish study of 43,141 twin pairs[J].Hepatology,2005,41(5):1138-1143.
4Lyons MA,Wittenburg H.Cholesterol gallstone susceptibility loci:a mouse map,candidate gene evaluation,and guide to human LITH genes[J].Gastroenterology,2006,131(6):1943-1970.
5Puppala S,Dodd GD,Fowler S,et al.A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans[J].Am J Hum Genet,2006,78(3):377-392.
6Han T,Yuan W,Qin J,et al.A genome-wide scan for the susceptibility loci to cholelithiasis in Chinese population[J].Am J Hum Genet,2003,73(5):S498.
9Lammert F,Carey MC,Paigen B,et al.chromosomal organization of candidate genes involved in cholesterol gallstone formation:a murine gallstone map.Gastroenterology,2001,121:221-238.
10Rizzo G,Renga B,Mencarelli A,et al.Role of FXR in regulating bile acid homeostasis and relevance for human diseases.Curr Drug Targets Immune Endocr Metabol Disord,2005,5:289-303.
6Moschetta A, Bookout AL, Mangelsdorf DJ. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model [J].Nat Med, 2004,10( 12):1352-1358.
